Cartalax is commonly employed in the following investigational areas:

Dermal Fibroblast Modulation

Investigations utilize Cartalax to study its impact on the functional activity of skin fibroblasts. Researchers quantify the synthesis of structural proteins and examine the peptide’s role in counteracting markers of cellular senescence in in vitro aging models.

Chondrocyte Proliferation and Cartilage Homeostasis

In laboratory studies involving cartilage tissue cultures, Cartalax is used to observe the regulation of chondrocyte proliferation. Data from these models focus on the peptide’s influence on the metabolic status of cartilage cells under experimental conditions of oxidative stress or age-related decline.

Stem Cell Differentiation and Gene Expression

Cartalax is employed as a chemical probe to study the differentiation of human mesenchymal stem cells. Research focuses on how the peptide modulates the expression of genes involved in cell survival and lineage specification.

Renal Tissue Renewal Processes

Experimental models utilizing kidney tissue cultures employ Cartalax to investigate the regulation of cell renewal. Studies focus on the peptide’s ability to maintain cellular homeostasis in tissues derived from both young and aged experimental subjects.

Pathway / Mechanistic Context

The primary mechanism of action for Cartalax in research settings involves the epigenetic regulation of protein synthesis.

• Chromatin Interaction: Research suggests that Cartalax can interact directly with DNA structures, facilitating the transition of heterochromatin to euchromatin, which allows for the transcription of previously silenced genes.
• Synthesis Modulation: By influencing transcriptional activity, the peptide is studied for its ability to regulate the production of tissue-specific proteins necessary for matrix maintenance.
• Mitochondrial Signaling: Experimental data indicate that short peptides like Cartalax may influence mitochondrial respiration and ATP production in aged cell lines.

Preclinical Research Summary

Published preclinical literature documents investigations of Cartalax across multiple experimental models for pathway characterization:

• Skin Aging: Studies in aged fibroblast cultures have observed that treatment with Cartalax may enhance the synthesis of collagen and other extracellular matrix components.
• Cartilage Restoration: Data from chondrocyte assays suggest that the peptide can increase the proliferative index of cartilage cells, indicating a potential role in joint tissue homeostasis research.
• Renal Bioenergetics: Research in kidney cell models indicates that Cartalax may preserve the renewal capacity of cells by modulating markers of oxidative phosphorylation and metabolic efficiency.

Form & Analytical Testing

This material is produced via robust chemical synthesis and supplied as a lyophilized (freeze-dried) powder.

• Lyophilization: Removes water content under vacuum to maintain molecular integrity and extend shelf-life.
• Identity Verification: Each lot undergoes Mass Spectrometry (MS) to confirm the specific molecular weight and sequence identity of the tripeptide.
• Purity Verification: High-Performance Liquid Chromatography (HPLC) is performed to ensure the product meets the ≥99% purity standard required for reproducible research data.

Referenced Citations

References are provided for informational purposes only and are not clinical claims.

• Linkova, N., Drobintseva, A., Orlova, O., Kuznetsova, E., Polyakova, V., Kvetnoy, I., & Khavinson, V. (2016). Peptide Regulation of Skin Fibroblast Functions during Their Aging In Vitro. Bulletin of Experimental Biology and Medicine, 161, 175 – 178. https://doi.org/10.1007/s10517-016-3370-x
• Khavinson, V., Linkova, N., Diatlova, A., Gutop, E., & Orlova, O. (2020). [Short peptides: regulation of skin function during aging.]. Advances in gerontology = Uspekhi gerontologii, 33 1, 46-54. https://pubmed.ncbi.nlm.nih.gov/32362083/
• Khavinson, V. K.h, Tarnovskaia, S. I., Lin’kova, N. S., Poliakova, V. O., Durnova, A. O., Nichik, T. E., Kvetnoĭ, I. M., D’iakonov, M. M., & Iakutseni, P. P. (2014). Advances in gerontology = Uspekhi gerontologii, 27(4), 651–656. https://pubmed.ncbi.nlm.nih.gov/25946838/
• Chalisova, N. I., Lin’kova, N. S., Nichik, T. E., Ryzhak, A. P., Dudkov, A. V., & Ryzhak, G. A. (2015). Peptide Regulation of Cells Renewal Processes in Kidney Tissue Cultures from Young and Old Animals. Bulletin of experimental biology and medicine, 159(1), 124–127. https://doi.org/10.1007/s10517-015-2906-9
• Ashapkin, V., Khavinson, V., Shilovsky, G., Linkova, N., & Vanuyshin, B. (2020). Gene expression in human mesenchymal stem cell aging cultures: modulation by short peptides. Molecular biology reports, 47(6), 4323–4329. https://doi.org/10.1007/s11033-020-05506-3
• Caputi, S., Trubiani, O., Sinjari, B., Trofimova, S., Diomede, F., Linkova, N., Diatlova, A., & Khavinson, V. (2019). Effect of short peptides on neuronal differentiation of stem cells. International Journal of Immunopathology and Pharmacology, 33. https://doi.org/10.1177/2058738419828613
• Myakisheva, S., Linkova, N., Polyakova, V., & Ryzhak, G. (2023). PEPTIDES OF CARTILAGE TISSUE: REGULATION OF CHONDROCYTE PROLIFERATION, GEROPROTECTION AND PROSPECTS FOR USE IN OSTEOARTHROSIS. Vrach. https://doi.org/10.29296/25877305-2023-10-08

• Stable at room temperature for up to 90 days. For long-term storage, keep at -20°C (-4°F) or colder.
• Once mixed with a solvent (e.g., bacteriostatic water), the solution must be stored at 4 °C (39°F) and utilized within 30 days. Avoid repeated freeze-thaw cycles, as this degrades the peptide structure.

RESEARCH USE ONLY

This product is intended strictly for laboratory research use only. It is not for human or veterinary use. It is not intended for diagnosis, treatment, cure, or prevention of any disease. All purchases are subject to our Terms of Service and Purity Guarantee.

No COAs available for this product.